Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography

Figure 1

(a) Superficial capillary plexus of study patient before intravitreal treatment of bevacizumab. (b) Superficial capillary plexus of study patient after intravitreal treatment of bevacizumab. (c) Structural OCT B-scan before intravitreal treatment of bevacizumab.

(a)

(b)

(c)